Meeting program
All times are displayed in GMT+3
09:00 - 09:15 GMT+3 Opening Ceremony
09:15 - 10:15 GMT+3 Session 1: Lymphomas
Chairs: A Barefah (Saudi Arabia)
- Updates on Hodgkin Lymphoma
AJM Ferreri (Italy) - Updates on CART-Cells & bispecific antibodies in NHL
C Chabannon (France)
10:15 - 11:15 GMT+3 Session 2: Chronic Lymphoproliferative Disorders
Chair: O Radhwi (Saudi Arabia)
- Updates on CLL
R Foà (Italy) - Infection and inflammation as drivers of MZLs
M Ponzoni (Italy)
11:15 - 12:00 GMT+3 Special session: Myeloid malignancies
Chair: A Radhi (Bahrain) & S Unal (Türkiye)
- From clonal hematopoiesis to myeloid malignancy - Options for leukemia prevention?
K Gronbaek (Denmark) - Inherited bone marrow failure and diamond blackfan anemia
J De La Fuente (United Kingdom)
11:15 - 13:15 GMT+3 Prayer & Lunch
13:15 - 14:15 GMT+3 Session 3: Acute Leukemia Adults
Chair: S Bahashwan (Saudi Arabia) & L Kaynar (Türkiye)
- Novel insights into AML treatment
K Döhner (Germany) - Risk stratification for the treatment of ALL
J Trka (Czechia)
14:15 - 15:15 GMT+3 Session 4: Myeloma
Chair: H Alahwal (Saudi Arabia)
- Updates for front line therapy for newly diagnosed MM
R Mina (Italy) - Treatment of MM patients based on their frailty status
A Larocca (Italy) - Updates in using novel therapies and immunotherapies for multiple myeloma
D Coriu (Romania)
15:15 - 15:30 GMT+3 Coffee break
15:30 - 16:30 GMT+3 Regional Joint Symposium Sickle Cell Anemia & Thalassemia
Chair: M Qari (Saudi Arabia)
- Patient blood management
S Hindawi (Saudi Arabia) - Current and new concept in the management of thalassemia
A El-Beshlawy (Egypt) - Locally Manufactured Deferasirox versus Desferrioxamine in Thalassemia Major Patients
H Hadi Almusawi (Iraq)
16:30 - 17:30 GMT+3 Session 5: Thrombosis & Hemostasis
Chair: S Al Jaouni (Saudi Arabia)
- Decisions in clinical management
S Stanworth (United Kingdom) - Biomarkers and risk prediction of cancer associated thrombosis
Z Bagoly (Hungary)
17:30 - 17:45 GMT+3 Closing ceremony
Back